Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-08

FDA Approved: PHENOXYBENZAMINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for phenoxybenzamine hydrochloride manufactured by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • phenoxybenzamine hydrochloride (phenoxybenzamine hydrochloride)

Snippet

SUPPL AP for PHENOXYBENZAMINE HYDROCHLORIDE (PHENOXYBENZAMINE HYDROCHLORIDE)